Related Articles
Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: A phase II study
Maintenance immunotherapy in metastatic breast cancer
Prevention of methylnitrosourea-induced mammary cancers by 9-cis-retinoic acid and/or vitamin D3
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group
A phase II study of docetaxel weekly in combination with carboplatin every three weeks as first line chemotherapy in stage IIB-IV epithelial ovarian cancer: Neurological toxicity and quality-of-life evaluation